Erika Ruíz‐García

Author

Erika Ruíz‐García

Instituto Nacional de Cancerología ORCID

Also Known As

E Ruiz, E Ruiz-Garcia, E Ruiz-García, E. B. Ruiz-Garcia, E. B. Ruiz-García, E. Ruiz, E. Ruiz-Garcia, E. Ruiz-García, E. Ruíz-García, E.B. Ruiz

220

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cancerología Instituto Politécnico Nacional Universidad Nacional Autónoma de México Centro Medico Nacional Siglo XXI Universidad Autónoma de la Ciudad de México

About

Erika Ruíz‐García is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	394
2	Health Sciences	2	2	29
3	Natural Sciences	2	2	38
4	Public Health	2	2	39
5	Engineering	1	1	76

Erika Ruíz‐García

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated <i>KRAS</i> G12C Marwan Fakih, Lisa Salvatore, Taito Esaki, New England Journal of Medicine	2023	294
Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer Ali Flores‐Pérez, Laurence A. Marchat, Sergio Rodrı́guez-Cuevas, Scientific Reports	2016	79
Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol Rubiceli Medina‐Aguilar, Carlos Pérez‐Plasencia, Laurence A. Marchat, PLoS ONE Breast OncologyEngineeringEpigenetic ChangeGeneticsDna Methylation	2016	76
Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy. Mayra Ramos, Patricia Lorenzo-Luaces, N González Lazo, Cancer Biology & Therapy	2012	68
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19 Ziad Bakouny, Chris Labaki, Punita Grover, JAMA Oncology	2022	62
Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening Erika Ruíz‐García, Véronique Scott, C. Machavoine, British Journal of Cancer	2010	54
Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells Ali Flores‐Pérez, Laurence A. Marchat, Sergio Rodrı́guez-Cuevas, BMC Cancer	2016	50
Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer. Saúl Rodríguez‐Ramírez, Arizbeth Uribe, Erika Ruíz‐García, PubMed	2007	46
Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings Isabel Alvarado‐Cabrero, Georgia Alderete-Vázquez, Marissa Quintal-Ramírez, Annals of Diagnostic Pathology Hormone Receptor StatusBreast OncologyPathologic Complete ResponseMedicineGross Pathologic Findings	2009	44
Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non‐small cells lung cancer to chemotherapy Ali Flores‐Pérez, Laurence A. Marchat, Lidia López Sánchez, PROTEOMICS - CLINICAL APPLICATIONS	2015	41

Page 1